SCHEMBL13733501

SCHEMBL13733501

Nc1onc(-c2ccccc2Cl)c1C(=O)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.65
HTT P42858 2/20 0.65
ALDH1A1 P00352 4/20 0.59
TSHR P16473 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
KDM4E B2RXH2 1/20 0.55
EPAS1 Q99814 1/20 0.54
MAPK1 P28482 2/20 0.54
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.50
HIF1A Q16665 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
USP2 O75604 2/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734049 0.91 LMNA (0.66) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13736524 0.90 SMN1; SMN2 (0.52) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13732856 0.88 ALDH1A1 (0.64) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13733502 0.86 MAPT (0.48) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13733445 0.86 ALDH1A1 (0.61) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13733196 0.84 MAPT (0.51) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13733519 0.83 TSHR (0.54) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13733934 0.83 TSHR (0.64) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13734067 0.82 HTT (0.50) LMNAHTTALDH1A1TSHRSMN1; SMN2
SCHEMBL13735654 0.82 TSHR (0.60) LMNAHTTALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9132126-B2 Phenyl-isoxazole derivatives and preparation process thereof IL-YANG PHARM. CO., LTD. (KR) 2015-09-15 US claimed
EP-2699566-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF Il-Yang Pharm. Co., Ltd. (KR) 2014-02-26 EP claimed
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2014-01-30 US claimed
WO-2012144752-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2012-10-26 WO claimed
EP-2699566-B1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM CO LTD (KR) 2017-02-22 EP disclosed
US-9132126-B2 Phenyl-isoxazole derivatives and preparation process thereof IL-YANG PHARM. CO., LTD. (KR) 2015-09-15 US disclosed
EP-2699566-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF Il-Yang Pharm. Co., Ltd. (KR) 2014-02-26 EP disclosed
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2014-01-30 US disclosed
WO-2012144752-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2012-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF PIR, ALPL, PIGS LMNA 1031/4885HTT 2879/4885ALDH1A1 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.